Navigation Links
Hepatitis B Foundation to Host Annual Crystal Ball Gala
Date:1/14/2014

Doylestown, PA (PRWEB) January 14, 2014

Date: Friday, April 11, 2014

Time: 6 p.m. – 11 p.m.

Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa.

Details: The Hepatitis B Foundation, the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide, will host its annual Crystal Ball on Friday, April 11 at Warrington Country Club in Warrington, Pa.

Each year, the Crystal Ball attracts hundreds of leaders from the community, academic institutions, government, health care industry and biotech executives. The gala evening is a fundraiser for the foundation, with all proceeds benefitting its global research, outreach and patient advocacy programs.

This year’s event, the “Cherry Blossom Extravaganza,” includes an evening of dinner, dancing, a silent auction and awards ceremony. The Foundation will honor Dr. Thomas Starzl with the 2014 Baruch S. Blumberg Prize for pioneering the first human liver transplant in 1963.

Foundation leaders also will announce the recipients of the 2014 Community Commitment Award, Teri and Jim Holton, of Doylestown. Both have provided generous support to the Hepatitis B Foundation with Teri serving as chair of the Crystal Ball auction committee for the past four years and making it a tremendous success. In addition, Teri volunteers regularly in the community and her church and Jim supports many local food pantries with donations from Kellogg where he is a senior vice president.

The Hepatitis B Foundation is accepting auction items and sponsorship opportunities are still available. For more information regarding the Crystal Ball, call 215-489-4900.

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to http://www.hepb.org, read our blog at http://wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call 215-489-4900.

Contact: Sarah Larson at sarah(at)furiarubel(dot)com or 215-340-0480

Read the full story at http://www.prweb.com/releases/2014/01/prweb11488785.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
2. FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients
3. EU Should Better Prevent Citizens From Hepatitis, Says Liver Patients Organisation ELPA
4. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
5. The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
6. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
7. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
8. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. A Phase IIa Interferon Free Combination Hepatitis C Trial of Simeprevir (TMC435) and TMC647055 Will Commence Shortly
11. Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  HUYA Bioscience International, (HUYA), ... China,s pharmaceutical innovations, announced today a ... Innovation and Investment Company (referred to as CAS Innovation). ... innovations discovered by leading scientists at CAS to meet ... HUYA is the first company to have recognized ...
(Date:1/17/2017)... West Point, IA (PRWEB) , ... January 17, ... ... approval from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance ... tolerance to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean ...
(Date:1/17/2017)... Mass. , Jan. 17, 2017   Pulmatrix, ... stage biopharmaceutical company developing innovative inhaled therapies to address ... for treating fungal infections in the lungs of CF ... Disease Product" (QIDP) by the U.S. Food & Drug ... which is designed to speed the development of novel ...
(Date:1/17/2017)... UK (PRWEB) , ... January ... ... presented by surgeons at the 2016 annual meeting of the North American ... clinical outcomes, for patients in the majority of cases, when PEEK-OPTIMA™ HA ...
Breaking Biology Technology:
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/20/2016)... Dec. 20, 2016 The rising popularity ... and leasing is stoking significant interest in keyless ... technology, Bluetooth low energy (BLE), biometrics and near-field ... next wave of wireless technologies in the automotive ... to advanced access systems opens the market to ...
Breaking Biology News(10 mins):